Complement Factor H Polymorphism and Age-Related Macular Degeneration
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is a common, late-onset, and complex trait with multiple risk factors. Concentrating on a region harboring a locus for AMD on 1q25-31, the ARMD1 locus, we tested single-nucleotide polymorphisms for association with AMD in two independent case-control populations. Significant association ( P = 4.95 × 10 -10 ) was identified within the regulation of complement activation locus and was centered over a tyrosine-402 → histidine-402 protein polymorphism in the gene encoding complement factor H. Possession of at least one histidine at amino acid position 402 increased the risk of AMD 2.7-fold and may account for 50% of the attributable risk of AMD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A major AMD-associated SNP is the Y402H (tyrosine to histidine substitution at amino acid 402) variant of complement factor H (CFH) (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Edwards et al., 2005
In the citing paper
“These SNPs have been reported to be major genetic factors for developing AMD in Caucasians (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005; Tuo et al., 2006).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Edwards et al., 2005
In the citing paper
“Complement activation playing a major role in AMD pathogenesis is yet another source of inflammation [107-110].”
From Risk mitigation of immunogenicity: a key to personalized retinal gene therapy (2021) · cites this paper as [108]
In the citing paper
“Polymorphisms in human complement regulatory factor H (CFH) predispose individuals to AMD [35, 46, 59]”
From Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain (2022) · cites this paper as [35]
In the citing paper
“Genes in the complement pathway4–11 and a region of chromosome 10 12,13 have now been implicated as the major genetic contributors to disease.”
From Seven new loci associated with age-related macular degeneration (2013) · cites this paper as [4]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Haploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,525
Prevalence of Age-Related Macular Degeneration in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.564 · Cited by 2,736
Score Tests for Association between Traits and Haplotypes when Linkage Phase Is Ambiguous
Schaid, D. J., Rowland, C. M., Tines, D. E., Jacobson, R. M., & Poland, G. A. (2002) · The American Journal of Human Genetics · doi:10.1086/338688 · Cited by 1,783
The Five-year Incidence and Progression of Age-related Maculopathy
Klein, R., Klein, B. E. K., Jensen, S. C., & Meuer, S. M. (1997) · Ophthalmology · doi:10.1016/s0161-6420(97)30368-6 · Cited by 1,135
Mullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937
The epidemiology of age-related macular degeneration
Klein, R., Peto, T., Bird, A., & Vannewkirk, M. R. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2003.11.069 · Cited by 932
Johnson, L. V., Leitner, W. P., Staples, M. K., & Anderson, D. H. (2001) · Experimental Eye Research · doi:10.1006/exer.2001.1094 · Cited by 621
Molecular Biology and Chemistry of the Alternative Pathway of Complement
Müller-Eberhard, H. J., & Schreiber, R. D. (1980) · Advances in Immunology · doi:10.1016/s0065-2776(08)60042-5 · Cited by 408
Seddon, J. M. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.6.785 · Cited by 398
Keenan, T. D., & Chew, E. Y. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.2210 · Cited by 377
Research works printed but not linked: 1
- M. H. Wener, P. R. Daum, G. M. McQuillan, J. Rheumatol.27, 2351 (2000).
Cited by
Items 301–400 of 1,021
Sjöberg, A. P., Trouw, L. A., Clark, S. J., Sjölander, J., Heinegård, D., Sim, R. B., Day, A. J., & Blom, A. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610256200 · Cited by 142
The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice
Fu, L., Garland, D., Yang, Z., Shukla, D., Rajendran, A., Pearson, E., Stone, E. M., Zhang, K., & Pierce, E. A. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm198 · Cited by 143
Vitreomacular Adhesion in Active and End-Stage Age-related Macular Degeneration
Robison, C. D., Krebs, I., Binder, S., BARBAZETTO, I. A., Kotsolis, A. I., Yannuzzi, L. A., Sadun, A. A., & Sebag, J. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.01.014 · Cited by 155
Age-related Macular Degeneration: Genetic and Environmental Factors of Disease
Chen, Y., Bedell, M., & Zhang, K. (2010) · Molecular Interventions · doi:10.1124/mi.10.5.4 · Cited by 162
“Specifically, risk of developing AMD is associated with an allele of CFH in which a histidine residue is encoded in place of a tyrosine residue at amino acid position 402 (16, 57, 58).”
BackgroundExome sequencing and complex disease: practical aspects of rare variant association studies
Do, R., Kathiresan, S., & Abecasis, G. R. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds387 · Cited by 137
Serum Lipid Biomarkers and Hepatic Lipase Gene Associations with Age-Related Macular Degeneration
Reynolds, R., Rosner, B., & Seddon, J. M. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.07.009 · Cited by 140
“High-density lipoprotein cholesterol 1 27 (19) 90 (28) 2 39 (28) 78 (25) 3 32 (23) 80 (25) 4 42 (30) 70 (22)”
Zarbin, M. A., & Rosenfeld, P. J. (2010) · Retina · doi:10.1097/iae.0b013e3181f57e30 · Cited by 140
Bazan, N. G., Calandria, J. M., & Serhan, C. N. (2010) · Journal of Lipid Research · doi:10.1194/jlr.r001131 · Cited by 140
Kondo, N., Honda, S., Ishibashi, K., Tsukahara, Y., & Negi, A. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.06.003 · Cited by 144
Vélez-Montoya, R., Oliver, S. C. N., Olson, J. L., Fine, S. L., Quiroz-Mercado, H., & Mandava, N. (2013) · Retina · doi:10.1097/iae.0000000000000036 · Cited by 156
Mechanism of Inflammation in Age-Related Macular Degeneration
Parmeggiani, F., Romano, M. R., Costagliola, C., Semeraro, F., Incorvaia, C., D’Angelo, S., Perri, P., De Palma, P., De Nadai, K., & Sebastiani, A. (2012) · Mediators of Inflammation · doi:10.1155/2012/546786 · Cited by 135
Complement Activation by Bisretinoid Constituents of RPE Lipofuscin
Zhou, J., Kim, S. R., Westlund, B. S., & Sparrow, J. R. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2868 · Cited by 141
Age-Related Macular Degeneration and Risk for Stroke
Wong, T. Y., Klein, R., Sun, C., Mitchell, P., Couper, D. J., Lai, H., Hubbard, L. D., Sharrett, A. R., & Study, F. T. A. R. I. C. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-2-200607180-00007 · Cited by 136
“Genetic factors, such as polymorphisms of the genes for apolipoprotein E (37, 38) and complement pathways (13, 14), may also contribute to the development of both conditions.”
BackgroundTortajada, A., Montes, T., Martinez-Barricarte, R., Morgan, B. P., Harris, C. L., & de Cordoba, S. R. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp289 · Cited by 137
“However, only MPGN2/DDD and AMD have pathological similarities.”
InfluentialEbrahimi, K. B., Fijalkowski, N., Cano, M., & Handa, J. T. (2013) · The Journal of Pathology · doi:10.1002/path.4128 · Cited by 133
Inflammaging in Skin and Other Tissues - The Roles of Complement System and Macrophage
Zhuang, Y., & Lyga, J. (2014) · Inflammation & Allergy-Drug Targets · doi:10.2174/1871528113666140522112003 · Cited by 132
“For example, a CFH polymorphism, which resulted in an amino acid substitution of histidine for tyrosine (Y402H), is strongly associated with the risk of AMD [29, 34, 35].”
BackgroundFeigl, B. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.11.004 · Cited by 149
“Plasma levels of complement factor H are significantly lower in smokers (Esparza-Gordillo et al., 2004) and a polymorphism in the gene coding for complement factor H has been repeatedly shown in ARM (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005).”
BackgroundInfluentialAge-related macular degeneration: genome-wide association studies to translation
Black, J. R. M., & Clark, S. J. (2016) · Genetics in Medicine · doi:10.1038/gim.2015.70 · Cited by 136
Age-related macular degeneration: diagnosis and management
Cook, H. L., Patel, P. J., & Tufail, A. (2008) · British Medical Bulletin · doi:10.1093/bmb/ldn012 · Cited by 131
Kortvely, E., Hauck, S. M., Duetsch, G., Gloeckner, C. J., Kremmer, E., Alge-Priglinger, C. S., Deeg, C. A., & Ueffing, M. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-3850 · Cited by 135
Lee, A. Y., Raya, A. K., Kymes, S. M., Shiels, A., & Brantley, M. A. (2009) · British Journal of Ophthalmology · doi:10.1136/bjo.2008.150995 · Cited by 134
The role of complement system in ocular diseases including uveitis and macular degeneration
Jha, P., Bora, P. S., & Bora, N. S. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.06.145 · Cited by 139
Complement in therapy and disease
Melis, J. P. M., Strumane, K., Ruuls, S. R., Beurskens, F. J., Schuurman, J., & Parren, P. W. H. I. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.01.028 · Cited by 125
“Since the initial demonstration of n association between complement Factor H polymorphisms and MD (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 005; Klein et al., 2005), additional associations between AMD nd other complement component polymorphisms have become pparent (C2, C3, C7, Factor B, Factor D, Fa…”
BackgroundMitochondrial DNA Haplogroups Associated with Age-Related Macular Degeneration
Udar, N., Atilano, S. R., Memarzadeh, M., Boyer, D. S., Chwa, M., Lu, S., Maguen, B., Langberg, J., Coskun, P., Wallace, D. C., et al. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2646 · Cited by 130
IRON TOXICITY AS A POTENTIAL FACTOR IN AMD
WONG, R. W., RICHA, D. C., HAHN, P., GREEN, W. R., & DUNAIEF, J. L. (2007) · Retina · doi:10.1097/iae.0b013e318074c290 · Cited by 131
Regulation of regulators: Role of the complement factor H-related proteins
Cserhalmi, M., Papp, A., Brandus, B., Uzonyi, B., & Józsi, M. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.101341 · Cited by 131
An, E., Lu, X., Flippin, J., Devaney, J. M., Halligan, B., Hoffman, E., Csaky, K., & Hathout, Y. (2006) · Journal of Proteome Research · doi:10.1021/pr060121j · Cited by 130
Cigarette Smoking, CFH, APOE, ELOVL4, and Risk of Neovascular Age-Related Macular Degeneration
DeAngelis, M. M. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.1.49 · Cited by 130
Yakub, I., Lillibridge, K. M., Moran, A., Gonzalez, O. Y., Belmont, J. W., Gibbs, R. A., & Tweardy, D. J. (2005) · The Journal of Infectious Diseases · doi:10.1086/497340 · Cited by 137
“These findings were confirmed by the same research group using a larger data set and by 2 other groups [35, 36].”
ResultComplement in removal of the dead – balancing inflammation
Martin, M., & Blom, A. M. (2016) · Immunological Reviews · doi:10.1111/imr.12462 · Cited by 130
Age-related macular degeneration and the immune response: implications for therapy
Nussenblatt, R. B., & Ferris, F. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.06.025 · Cited by 130
Prevalence and Genomic Association of Reticular Pseudodrusen in Age-Related Macular Degeneration
Ueda‐Arakawa, N., Ooto, S., Nakata, I., Yamashiro, K., Tsujikawa, A., Oishi, A., & Yoshimura, N. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2012.08.011 · Cited by 134
Age-related macular degeneration and the role of the complement system
McHarg, S., Clark, S. J., Day, A. J., & Bishop, P. N. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.02.032 · Cited by 138
Sustained suppression of VEGF for treatment of retinal/choroidal vascular diseases
Campochiaro, P. A., & Akhlaq, A. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100921 · Cited by 140
Chen, H., Liu, B., Lukas, T. J., & Neufeld, A. H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002339 · Cited by 129
A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study
Murabito, J. M., Rosenberg, C. L., Finger, D., Kreger, B. E., Levy, D. A., Splansky, G. L., Antman, K. H., & Hwang, S. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-s1-s6 · Cited by 132
“In a recent small GWAS of age-related macular degeneration that included 96 cases and 50 controls, an association with the CFH gene was identified [40] and confirmed in larger studies [41-43].”
ResultNita, M., Grzybowski, A. E., Ascaso, F. J., & Huerva, V. (2014) · Mediators of Inflammation · doi:10.1155/2014/930671 · Cited by 136
“Soft drusen contain also numerous mediators of inflammation such as C-reactive protein (CRP) [13, 56], adducts of the carboxyethylpyrrole protein (CEP) [57], immunoglobulins (IgG) [58], acute phase molecules (vitronectin, amyloid P, and fibrinogen), and apolipoproteins [59] as well as many…”
BackgroundMiki, A., Kondo, N., Yanagisawa, S., Bessho, H., Honda, S., & Negi, A. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.11.020 · Cited by 133
High concentration of zinc in sub-retinal pigment epithelial deposits
Lengyel, I., Flinn, J. M., Pető, T., Linkous, D. H., Cano, K., Bird, A. C., Lanzirotti, A., Frederickson, C. J., & van Kuijk, F. J. G. M. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2006.12.015 · Cited by 141
Iron homeostasis and eye disease
Loh, A., Hadziahmetovic, M., & Dunaief, J. L. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.11.001 · Cited by 126
Epithelial phenotype and the RPE: Is the answer blowing in the Wnt?
BURKE, J. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.08.002 · Cited by 124
“The identification a few years ago of genes that confer AMD risk had a major impact on AMD research (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005), but how aging itself contributes to disease onset, progression and severity remain important questions, and oxidative stress has lon…”
BackgroundBhutto, I. A., Baba, T., Merges, C., Juriasinghani, V., McLeod, D. S., & Lutty, G. A. (2011) · British Journal of Ophthalmology · doi:10.1136/bjo.2010.199216 · Cited by 126
Rapid differentiation of the human RPE cell line, ARPE-19, induced by nicotinamide
Hazim, R. A., Volland, S., Yen, A., Burgess, B. L., & Williams, D. S. (2019) · Experimental Eye Research · doi:10.1016/j.exer.2018.10.009 · Cited by 126
“The importance of the RPE for proper vision is underscored by several retinal degenerative diseases that involve RPE pathology, including age-related macular degeneration (AMD) (Bhutto and Lutty, 2012).”
BackgroundInfluentialThe continuum of causality in human genetic disorders
Katsanis, N. (2016) · Genome Biology · doi:10.1186/s13059-016-1107-9 · Cited by 127
Francis, P. J., Hamon, S. C., Ott, J., Weleber, R. G., & Klein, M. L. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.062737 · Cited by 123
The Genetic Basis of Complex Traits
Iyengar, S. K., & Elston, R. C. (2007) · Methods in Molecular Biology™ · doi:10.1007/978-1-59745-389-9_6 · Cited by 118
Bora, N. S., Kaliappan, S., Jha, P., Xu, Q., Sohn, J.-H., Dhaulakhandi, D. B., Kaplan, H. J., & Bora, P. S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1872 · Cited by 124
Kaarniranta, K., Salminen, A., Eskelinen, E., & Kopitz, J. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.01.001 · Cited by 135
Elevated membrane attack complex in human choroid with high risk complement factor H genotypes
Mullins, R. F., Dewald, A. D., Streb, L. M., Wang, K., Kuehn, M. H., & Stone, E. M. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.06.015 · Cited by 122
“, 2006), and, most notably, complement factor H (CFH) (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005).”
Serum cytokines as biomarkers for age-related macular degeneration
Nassar, K., Grisanti, S., Elfar, E., Lüke, J., Lüke, M., & Grisanti, S. (2014) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-014-2738-8 · Cited by 126
“Later, molecular and clinical evidence was provided [5].”
BackgroundClark, S. J., Schmidt, C. Q., White, A. M., Hakobyan, S., Morgan, B. P., & Bishop, P. N. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401613 · Cited by 122
Cheung, C. M. G., & Wong, T. Y. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12227 · Cited by 116
Genetic variants in the complement system predisposing to age-related macular degeneration: A review
Schramm, E. C., Clark, S. J., Triebwasser, M. P., Raychaudhuri, S., Seddon, J. M., & Atkinson, J. P. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.06.032 · Cited by 121
“Subsequent genetic studies identified a common single nucleotide polymorphism (SNP) in the CFH gene (rs1061170) (Figure 2A) that is associated with increased risk of developing AMD (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005).”
BackgroundHayashi, H., Yamashiro, K., Gotoh, N., Nakanishi, H., Nakata, I., Tsujikawa, A., Otani, A., Saito, M., Iida, T., Matsuo, K., et al. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5554 · Cited by 127
Yu, Y., Reynolds, R., Rosner, B., Daly, M. J., & Seddon, J. M. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-8657 · Cited by 119
A role of macrophage complement receptor CRIg in immune clearance and inflammation
He, J. Q., Wiesmann, C., & Campagne, M. V. L. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.07.011 · Cited by 138
Ceruloplasmin/hephaestin knockout mice model morphologic and molecular features of AMD
Hadziahmetovic, M., Dentchev, T., Song, Y., Haddad, N., He, X., Hahn, P., Pratico, D., Wen, R., Harris, Z. L., Lambris, J. D., et al. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1472 · Cited by 121
Yu, Y., Reynolds, R., Fagerness, J., Rosner, B., Daly, M. J., & Seddon, J. M. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-7070 · Cited by 119
Identification of Novel Substrates for the Serine Protease HTRA1 in the Human RPE Secretome
An, E., Sen, S., Park, S. K., Gordish-Dressman, H., & Hathout, Y. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-4853 · Cited by 117
“SP, signal peptide domain (1-22) cleaved in mature secreted protein; IGFBP, insulin growth factor–binding protein domain (33-100); Kazal-like: Kazal-like domain, with a structure similar to that of Kazal-type serine protease inhibitors.”
MethodEvidence for an inflammatory process in age-related macular degeneration gains new support
Bok, D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502819102 · Cited by 120
A Review: Role of Ultraviolet Radiation in Age-Related Macular Degeneration
Chalam, K. V., Khetpal, V., Rusovici, R., & Balaiya, S. (2011) · Eye & Contact Lens Science & Clinical Practice · doi:10.1097/icl.0b013e31821fbd3e · Cited by 132
Genetic association with response to intravitreal ranibizumab in patients with neovascular AMD
Kloeckener-Gruissem, B., Barthelmes, D., Labs, S., Schindler, C., Kurz-Levin, M., Michels, S., Fleischhauer, J., Berger, W., Sutter, F., & Menghini, M. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6080 · Cited by 120
Cruz-Guilloty, F., Saeed, A. M., Echegaray, J. J., Duffort, S., Ballmick, A., Tan, Y., Betancourt, M., Viteri, E., Ramkhellawan, G. C., Ewald, E., et al. (2013) · International Journal of Inflammation · doi:10.1155/2013/503725 · Cited by 117
“Hindawi Publishing Corporation International Journal of Inflammation Volume 2013, Article ID 503725, 12 pages http://dx.doi.org/10.1155/2013/503725”
BackgroundInfluentialComplement factor H polymorphisms in Japanese population with age-related macular degeneration.
Okamoto, H., Umeda, S., Obazawa, M., MINAMI, M., Noda, T., Mizota, A., Honda, M., Tanaka, M., Koyama, R., Takagi, I., et al. (2006) · PubMed · Cited by 130
Wu, Z., Lauer, T. W., Sick, A., Hackett, S. F., & Campochiaro, P. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702321200 · Cited by 118
Age-Related Macular Degeneration: Epidemiology and Clinical Aspects
Keenan, T. D. L., Cukras, C. A., & Chew, E. Y. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-66014-7_1 · Cited by 134
Bazan, N. G. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0918 · Cited by 125
Lau, L.-I., Chen, S.-J., Cheng, C.-Y., Yen, M.-Y., Lee, F.-L., Lin, M.-W., Hsu, W.-M., & Wei, Y.-H. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1532 · Cited by 119
“Edwards et al.(15) noted that the association between AMD and the Y402H polymorphism largely resulted from an excess of 1277CC homozygosity among patients rather than controls.”
BackgroundGenetic and Functional Dissection of HTRA1 and LOC387715 in Age-Related Macular Degeneration
Yang, Z., Tong, Z., Chen, Y., Zeng, J., Lu, F., Sun, X., Zhao, C., Wang, K., Davey, L., Chen, H., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000836 · Cited by 114
Amyloid‐β(1‐42) alters structure and function of retinal pigmented epithelial cells
Bruban, J., Glotin, A., Dinet, V., Chalour, N., Sennlaub, F., Jonet, L., An, N., Faussat, A. M., & Mascarelli, F. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00456.x · Cited by 114
Age-related macular degeneration and changes in the extracellular matrix
Romaniuk, W. (2014) · Medical Science Monitor · doi:10.12659/msm.889887 · Cited by 131
Herbert, A. P., Deakin, J. A., Schmidt, C. Q., Blaum, B. S., Egan, C., Ferreira, V. P., Pangburn, M. K., Lyon, M., Uhrín, D., & Barlow, P. N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609636200 · Cited by 114
Ebrahem, Q., Renganathan, K., Sears, J., Vasanji, A., Gu, X., Lu, L., Salomon, R. G., Crabb, J. W., & Anand-Apte, B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601552103 · Cited by 117
Montes, T., Tortajada, A., Morgan, B. P., Rodríguez de Córdoba, S., & Harris, C. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812584106 · Cited by 112
“AMD ranges from less than 1% to more than 50% (20-28).”
BackgroundSeddon, J. M., Reynolds, R., Shah, H. R., & Rosner, B. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2010.12.020 · Cited by 115
Choroideremia: New Findings from Ocular Pathology and Review of Recent Literature
MacDonald, I. M., Russell, L., & Chan, C. (2009) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2009.02.008 · Cited by 120
“Localization of inflammatory elements such as complement factors, macrophages, and microglia in AMD lesions support the hypothesis that local inflammation, activation of the complement cascade, and possibly the systemic immune system, contribute to the pathogenesis of AMD.10,16,18,28,30,38,47 Genetic variants in immun…”
BackgroundInfluentialA glimmer of light for neuropsychiatric disorders
Hyman, S. E. (2008) · Nature · doi:10.1038/nature07454 · Cited by 130
Raoul, W., Auvynet, C., Camelo, S., Guillonneau, X., Feumi, C., Combadière, C., & Sennlaub, F. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-87 · Cited by 109
“A more recent discovery, that AMD is associated with a polymorphism of complement factor H (CfH) [13-15], a polymorphism that leads to an overactivation of the complement system [16,17], emphasizes the importance of inflammatory mediators in AMD.”
BackgroundZipfel, P. F., Wiech, T., Stea, E. D., & Skerka, C. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019050515 · Cited by 116
Phenotype and Genotype Characteristics of Age-related Macular Degeneration in a Japanese Population
Mori, K., Horie‐Inoue, K., Gehlbach, P. L., Takita, H., Kabasawa, S., Kawasaki, I., Ohkubo, T., Kurihara, S., Iizuka, H., Miyashita, Y., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2009.10.001 · Cited by 119
Suzuki, M., Tsujikawa, M., Itabe, H., Du, Z.-J., Xie, P., Matsumura, N., Fu, X., Zhang, R., Sonoda, K.-H., Egashira, K., et al. (2012) · Journal of Cell Science · doi:10.1242/jcs.097683 · Cited by 113
“AMD is a progressive, polygenic and multifactorial disease with a poorly understood etiology, although numerous studies have suggested the involvement of factors such as oxidative stress, inflammation, immune response and genetics in the onset of AMD (Baba et al., 2010; Edwards et al., 2005; Grossniklaus et al., 2002;…”
BackgroundCameron, D. J., Yang, Z., Gibbs, D., Chen, H., Kaminoh, Y., Jorgensen, A., Zeng, J., Luo, L., Brinton, E., Brinton, G., et al. (2007) · Cell Cycle · doi:10.4161/cc.6.9.4157 · Cited by 114
Tuo, J., Ning, B., Bojanowski, C. M., Lin, Z.-N., Ross, R. J., Reed, G. F., Shen, D., Jiao, X., Zhou, M., Chew, E. Y., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603485103 · Cited by 114
Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells
Skeie, J. M., Fingert, J. H., Russell, S. R., Stone, E. M., & Mullins, R. F. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-5322 · Cited by 114
Chen, M., Forrester, J. V., & Xu, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022818 · Cited by 108
Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases
Jones, M. K., Lü, B., Girman, S., & Wang, S. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.01.004 · Cited by 125
“For AMD, one of the first gene mutations discovered in humans was in the complement factor H (CFH) gene, and the Cfh−/− mouse has similar disease features including loss of photoreceptors, reduced rod function, and complement deposits; however, these animals also experience complications with glomerulonephritis and ca…”
BackgroundInfluentialJun, S., Datta, S., Wang, L., Pegany, R. B., Cano, M., & Handa, J. T. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.09.023 · Cited by 127
Radeke, M. J., Radeke, C. M., Shih, Y.-H., Hu, J., Bok, D., Johnson, L. V., & Coffey, P. J. (2015) · Genome Medicine · doi:10.1186/s13073-015-0183-x · Cited by 109
“In large part, the analysis focused on genes whose association has been corroborated in multiple studies or large cohort genome-wide association studies [58–97].”
ResultSynaptic Pathology, Altered Gene Expression, and Degeneration in Photoreceptors Impacted by Drusen
Johnson, P. T., Brown, M. N., Pulliam, B. C., Anderson, D. H., & Johnson, L. V. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0767 · Cited by 111
Microbes Bind Complement Inhibitor Factor H via a Common Site
Meri, T., Amdahl, H., Lehtinen, M. J., Hyvärinen, S., McDowell, J. V., Bhattacharjee, A., Meri, S., Marconi, R., Goldman, A., & Jokiranta, T. S. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003308 · Cited by 111
“Another important target binding region in FH is within domain 7 and polymorphism in this domain is strongly associated with age-related macular degeneration, the most common cause of blindness in elderly people in industrialized countries [10,11].”
Wong, J. H. C., Jessica, Y. W., Jobling, A. I., Brandli, A. A., Greferath, U., Fletcher, E. L., & Vessey, K. A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1009599 · Cited by 132
“Finally, the vascular cell classes (arteries, veins, and choriocapillaries) showed upregulation of COL8A1 (collagen type VIII alpha 1 chain) collagen expression, which suggests extracellular matrix remodeling, and upregulation in CFH in the alternative complement pathways, which could modulate MP interaction with the…”
BackgroundInfluentialLysyl Oxidase-like 1 Polymorphisms and Exfoliation Syndrome in the Japanese Population
Hayashi, H., Gotoh, N., Ueda, Y., Nakanishi, H., & Yoshimura, N. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.10.023 · Cited by 121
Complement dysregulation and disease: From genes and proteins to diagnostics and drugs
de Córdoba, S. R., Tortajada, A., Harris, C. L., & Morgan, B. P. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.021 · Cited by 123
Lipids, oxidized lipids, oxidation-specific epitopes, and Age-related macular degeneration.
Handa, J. T., Cano, M., Wang, L., Datta, S., & Liu, T. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.07.013 · Cited by 112
Neovascular Age-Related Macular Degeneration Risk Based on CFH, LOC387715/HTRA1, and Smoking
Hughes, A. E., Orr, N., Patterson, C., Esfandiary, H., Hogg, R., McConnell, V., Silvestri, G., & Chakravarthy, U. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040355 · Cited by 108
“Several polymorphisms in CFH, the gene encoding complement factor H, were found to be strongly associated with AMD, and single nucleotide polymorphism (SNP) rs1061170, encoding a nonsynonymous change from tyrosine to histidine at codon 402, was proposed as the main determinant of disease [14–18].”
BackgroundKenney, M. C., Chwa, M., Atilano, S. R., Falatoonzadeh, P., Ramírez, C., Malik, D., Tarek, M., Cáceres‐del‐Carpio, J., Nesburn, A. B., Boyer, D. S., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu065 · Cited by 116
Complement in multiple sclerosis: its role in disease and potential as a biomarker
Ingram, G., Hakobyan, S., Robertson, N. P., & Morgan, B. P. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03830.x · Cited by 110
Li, M., Boehnke, M., & Abecasis, G. R. (2006) · The American Journal of Human Genetics · doi:10.1086/503711 · Cited by 112
Yu, Y., Triebwasser, M. P., Wong, E. K. S., Schramm, E. C., Thomas, B., Reynolds, R., Mardis, E. R., Atkinson, J. P., Daly, M., Raychaudhuri, S., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu226 · Cited by 108
Association of complement factor H polymorphisms with exudative age-related macular degeneration.
Chen, L. J., Liu, D. T. L., Tam, P. O. S., Chan, W. M., Liu, K., Chong, K. K. L., Lam, D. S. C., & Pang, C. P. (2006) · PubMed · Cited by 124
Metadata
- Authors
- Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A.
- Affiliations
- Boston University (US)
- Corresponding author
- Edwards, Albert O.
- Venue
- Science
- Published
- 2005-04-15
- Volume
- 308
- Issue
- 5720
- Pages
- 421-424
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W3145351529
- Cited by
- 2,449
- References
- 30
- Citations by year
- 2026: 24 · 2025: 41 · 2024: 51 · 2023: 48 · 2022: 78 · 2021: 105 · 2020: 73 · 2019: 52 · 2018: 81 · 2017: 65 · 2016: 89 · 2015: 120 · 2014: 141 · 2013: 146 · 2012: 166
- FWCI
- 195.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Eye Institute (EY014467, R01EY014467)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- age-related macular degeneration, complement factor H, CFH Y402H polymorphism, single nucleotide polymorphisms, genetic association, disease risk
- MeSH terms
- Aged, Alleles, Chromosomes, Human, Pair 1, Complement Activation, Female, Gene Frequency, Multigene Family, Genotype, Haplotypes, Histidine, Homozygote, Humans, Macular Degeneration, Male, Middle Aged, Risk Factors, Tyrosine, Genetic Variation, Linkage Disequilibrium, Case-Control Studies, Complement Factor H, Amino Acid Substitution, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.